Work

Supplementary Table S2 from SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma

Year: 2024

Type: supplementary-materials

Abstract: Grade 3+ Adverse Events

DOI: 10.1158/1078-0432.27030646

Authors: Lisa A. Kottschade, Gregory Russell. Pond, Anthony J. Olszanski, Yousef Zakharia, Evidio Domingo-Musibay, Ralph J. Hauke, Brendan D. Curti, Sarah Schober, Mohammed M. Milhem, Matthew S. Block, Tina Hieken, Robert R. McWilliams

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402801119

Cites:

Cited by:

Related to: 9